#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B without inhibitors Langerhans cell sarcoma Paroxysmal nocturnal haemoglobinuria Small cell lung cancer recurrent Bone marrow disorder Cryoglobulinaemia Thromboangiitis obliterans Autoinflammation with infantile enterocolitis Congenital disorder of glycosylation Neonatal asphyxia Congenital leptin deficiency Waldenstrom's macroglobulinaemia recurrent Amyotrophic lateral sclerosis gene carrier Ovarian cancer Juvenile idiopathic arthritis More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Basic Information Crigler-Najjar syndrome – Basic Information Erdheim-Chester disease – Diagnostics Burkitt’s lymphoma – Trials in Disease Cystic fibrosis – Life with Disease Loeys-Dietz syndrome Haemophilia A without inhibitors – Life with Disease Leiomyosarcoma recurrent – Diagnostics Osteosarcoma metastatic – Life with Disease Noonan syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    2,4 DICHLOROBENZYL ALCOHOL Specific Nucleic Acid Sna-Her1 Lysine Aspirin Rtx001 Resatorvid Dexamethasone Acetate Regtivex METAMIZOLE SODIUM Darovasertib Skb264 Pyridoxine Hydrochloride Oteracil Tilsotolimod Sodium Domperidone Ltp001 Lutetium (177Lu) Edotreotide Elritercept Tucidinostat ENSIFENTRINE Duvakitug More therapies…

    Learn about Your Condition

    Primary hyperaldosteronism Alagille syndrome Breast cancer metastatic Adenocarcinoma gastric Chorioretinitis Suicidal ideation Sepsis Brain stem glioma Ligament operation Arterial tortuosity syndrome Non-obstructive cardiomyopathy Congenital pseudarthrosis Ureteric cancer Notalgia paraesthetica Ocular melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Evaluating Technetium-99m and Cyanine-5 PSMA Tracer-Guided Surgery for Patients with Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 99MTC-EUK-(SO3)CY5-MAS3
    The Netherlands

  • Safety and Effectiveness of Intravenous Sonazoid for Contrast-Enhanced Liver Ultrasound in Children with Focal Liver Lesions

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Perflubutane
    Germany Italy

  • Study on Fecal Microbiota Transplantation and Amoxicillin-Clavulanic Acid for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    France

  • Study on the Safety and Tolerability of Tamoxifen in Cystic Fibrosis Patients Not Eligible for CFTR Modulator Therapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Tamoxifen
    Italy

  • Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Valemetostat Tosilate
    • Datopotamab Deruxtecan
    • Trastuzumab Deruxtecan
    France Italy Spain

  • Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • BUDOPRUTUG
    Bulgaria Greece Spain
Previous Page
1 … 783 784 785 786 787 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!